AR030095A1 - PHARMACEUTICAL COMPOSITION CONTAINING CITALOPRAM - Google Patents
PHARMACEUTICAL COMPOSITION CONTAINING CITALOPRAMInfo
- Publication number
- AR030095A1 AR030095A1 ARP010103662A ARP010103662A AR030095A1 AR 030095 A1 AR030095 A1 AR 030095A1 AR P010103662 A ARP010103662 A AR P010103662A AR P010103662 A ARP010103662 A AR P010103662A AR 030095 A1 AR030095 A1 AR 030095A1
- Authority
- AR
- Argentina
- Prior art keywords
- citalopram
- pharmaceutical composition
- composition containing
- pharmaceutically acceptable
- containing citalopram
- Prior art date
Links
- 229960001653 citalopram Drugs 0.000 title abstract 4
- WSEQXVZVJXJVFP-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile Chemical compound O1CC2=CC(C#N)=CC=C2C1(CCCN(C)C)C1=CC=C(F)C=C1 WSEQXVZVJXJVFP-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 abstract 3
- 239000013078 crystal Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000007907 direct compression Methods 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000007892 solid unit dosage form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una forma de dosificacion unitaria solida que comprende citalopram, que se prepara por compresion directa de una mezcla de citalopram base, o una de sus sales farmacéuticamente aceptables, y excipientes farmacéuticamente aceptables, o rellenando dicha mezcla en una cápsula de gelatina dura. Cristales grandes de una sal farmacéuticamente aceptable de citalopram y método para la fabricacion de dichos cristales grandes.A solid unit dosage form comprising citalopram, which is prepared by direct compression of a mixture of citalopram base, or a pharmaceutically acceptable salt thereof, and pharmaceutically acceptable excipients, or by filling said mixture in a hard gelatin capsule. Large crystals of a pharmaceutically acceptable salt of citalopram and method for the manufacture of said large crystals.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200001202 | 2000-08-10 | ||
| DKPA200001614 | 2000-10-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR030095A1 true AR030095A1 (en) | 2003-08-13 |
Family
ID=26068858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010103662A AR030095A1 (en) | 2000-08-10 | 2001-07-31 | PHARMACEUTICAL COMPOSITION CONTAINING CITALOPRAM |
Country Status (34)
| Country | Link |
|---|---|
| EP (1) | EP1318805A2 (en) |
| JP (1) | JP2003531153A (en) |
| KR (1) | KR20030024833A (en) |
| CN (1) | CN1446089A (en) |
| AR (1) | AR030095A1 (en) |
| AT (1) | AT5744U1 (en) |
| AU (2) | AU2001100198B4 (en) |
| BE (1) | BE1013559A6 (en) |
| BG (1) | BG107578A (en) |
| BR (1) | BR0113250A (en) |
| CA (1) | CA2353693C (en) |
| CH (2) | CH694241A5 (en) |
| CZ (1) | CZ2003397A3 (en) |
| DE (2) | DE20113195U1 (en) |
| EA (1) | EA200300247A1 (en) |
| ES (1) | ES2172481B2 (en) |
| FI (1) | FI5176U1 (en) |
| FR (1) | FR2812811B1 (en) |
| GB (1) | GB2368014B (en) |
| GR (1) | GR1004193B (en) |
| HR (1) | HRP20030054A2 (en) |
| HU (1) | HUP0103071A3 (en) |
| IE (1) | IES20010693A2 (en) |
| IL (1) | IL154050A0 (en) |
| IS (1) | IS6021A (en) |
| IT (1) | ITMI20011637A1 (en) |
| MX (1) | MXPA03000837A (en) |
| NL (1) | NL1018741C1 (en) |
| NO (1) | NO20013891L (en) |
| NZ (1) | NZ523785A (en) |
| PL (1) | PL359824A1 (en) |
| SK (1) | SK2842003A3 (en) |
| WO (1) | WO2001080619A2 (en) |
| YU (1) | YU9003A (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2353693C (en) * | 2000-08-10 | 2003-07-22 | H. Lundbeck A/S | Pharmaceutical composition containing citalopram |
| AU2001100195B4 (en) * | 2001-01-05 | 2001-12-20 | H Lundbeck As | Pharmaceutical composition containing citalopram. |
| GB0206708D0 (en) * | 2002-03-21 | 2002-05-01 | Cipla Ltd | Pharmaceutical salts |
| US6812355B2 (en) | 2002-10-22 | 2004-11-02 | Sekhsaria Chemicals Limited | Process for the manufacture of citalopram hydrobromide from 5-bromophthalide |
| BR0317623A (en) * | 2002-12-23 | 2005-11-29 | Lundbeck & Co As H | Escitalopram, pharmaceutical composition, and use of escitalopram hydrobromide |
| WO2004103361A2 (en) * | 2003-05-20 | 2004-12-02 | Ranbaxy Laboratories Limited | A pharmaceutical dosage form of citalopram |
| HU227491B1 (en) * | 2003-11-25 | 2011-07-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Tablet containing citalopram hydrogen bromide |
| WO2006038217A1 (en) * | 2004-10-05 | 2006-04-13 | Strides Acrolab Limited | An improved drug delivery system of citalopram hydrobromide and process for producing the same |
| US7834201B2 (en) | 2005-06-22 | 2010-11-16 | H. Lundbeck A/S | Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| CN100353939C (en) * | 2006-01-05 | 2007-12-12 | 昆明积大制药有限公司 | Antidepressant composition containing citalopram and cyclodextrin |
| GB2446847B (en) * | 2007-02-02 | 2012-02-22 | Ubiquisys Ltd | Location of Basestation |
| WO2017020841A1 (en) * | 2015-08-03 | 2017-02-09 | 深圳信立泰药业股份有限公司 | Pharmaceutical composition containing lcz696 and preparation method thereof |
| WO2022153262A1 (en) * | 2021-01-18 | 2022-07-21 | Anton Frenkel | Pharmaceutical dosage form |
| JP2026503161A (en) | 2023-02-07 | 2026-01-27 | キナスト ラッセ | Immediate release oral pharmaceutical formulation of escitalopram or its racemate with increased API content |
| CN116656399A (en) * | 2023-04-23 | 2023-08-29 | 攀钢集团西昌钢钒有限公司 | A parallel desulfurization tower group |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1358915A (en) * | 1919-04-14 | 1920-11-16 | Amici Domenico | Aeroplane |
| GB1358915A (en) * | 1971-09-13 | 1974-07-03 | Merck & Co Inc | Directly compressed tablet and composition therefor |
| GB1526331A (en) | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| GB8419963D0 (en) | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
| GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| US5296507A (en) * | 1990-09-06 | 1994-03-22 | H.Lundbeck A/S | Treatment of cerbrovascular disorders |
| EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of a drug by a serotonin 1A receptor antagonist |
| GB9714841D0 (en) * | 1997-07-14 | 1997-09-17 | Smithkline Beecham Plc | Treatment method |
| GB2357762B (en) * | 2000-03-13 | 2002-01-30 | Lundbeck & Co As H | Crystalline base of citalopram |
| US6977306B2 (en) | 2000-05-02 | 2005-12-20 | Sumitomo Chemical Company, Limited | Citalopram hydrobromide crystal and method for crystallization thereof |
| CA2353693C (en) * | 2000-08-10 | 2003-07-22 | H. Lundbeck A/S | Pharmaceutical composition containing citalopram |
-
2001
- 2001-07-24 CA CA002353693A patent/CA2353693C/en not_active Expired - Lifetime
- 2001-07-24 IS IS6021A patent/IS6021A/en unknown
- 2001-07-24 IE IE20010693A patent/IES20010693A2/en not_active IP Right Cessation
- 2001-07-26 HU HU0103071A patent/HUP0103071A3/en unknown
- 2001-07-26 AU AU2001100198A patent/AU2001100198B4/en not_active Expired
- 2001-07-27 IT IT2001MI001637A patent/ITMI20011637A1/en unknown
- 2001-07-30 EP EP01957768A patent/EP1318805A2/en not_active Withdrawn
- 2001-07-30 BR BR0113250-4A patent/BR0113250A/en not_active IP Right Cessation
- 2001-07-30 CN CN01813752A patent/CN1446089A/en active Pending
- 2001-07-30 NZ NZ523785A patent/NZ523785A/en unknown
- 2001-07-30 EA EA200300247A patent/EA200300247A1/en unknown
- 2001-07-30 CZ CZ2003397A patent/CZ2003397A3/en unknown
- 2001-07-30 SK SK284-2003A patent/SK2842003A3/en not_active Application Discontinuation
- 2001-07-30 YU YU9003A patent/YU9003A/en unknown
- 2001-07-30 WO PCT/DK2001/000520 patent/WO2001080619A2/en not_active Ceased
- 2001-07-30 KR KR10-2003-7001683A patent/KR20030024833A/en not_active Ceased
- 2001-07-30 PL PL01359824A patent/PL359824A1/en not_active Application Discontinuation
- 2001-07-30 IL IL15405001A patent/IL154050A0/en unknown
- 2001-07-30 JP JP2001577732A patent/JP2003531153A/en not_active Withdrawn
- 2001-07-30 HR HR20030054A patent/HRP20030054A2/en not_active Application Discontinuation
- 2001-07-30 MX MXPA03000837A patent/MXPA03000837A/en unknown
- 2001-07-30 AU AU2001279591A patent/AU2001279591A1/en not_active Abandoned
- 2001-07-31 AR ARP010103662A patent/AR030095A1/en not_active Application Discontinuation
- 2001-07-31 GB GB0118579A patent/GB2368014B/en not_active Expired - Fee Related
- 2001-07-31 GR GR20010100377A patent/GR1004193B/en unknown
- 2001-08-07 AT AT0062401U patent/AT5744U1/en not_active IP Right Cessation
- 2001-08-08 CH CH01422/03A patent/CH694241A5/en not_active IP Right Cessation
- 2001-08-08 CH CH01469/01A patent/CH694242A5/en not_active IP Right Cessation
- 2001-08-08 FR FR0110586A patent/FR2812811B1/en not_active Expired - Fee Related
- 2001-08-09 ES ES200101877A patent/ES2172481B2/en not_active Expired - Fee Related
- 2001-08-09 DE DE20113195U patent/DE20113195U1/en not_active Ceased
- 2001-08-09 FI FI20010303U patent/FI5176U1/en active
- 2001-08-09 NO NO20013891A patent/NO20013891L/en not_active Application Discontinuation
- 2001-08-09 DE DE10139115A patent/DE10139115A1/en not_active Ceased
- 2001-08-10 BE BE2001/0537A patent/BE1013559A6/en not_active IP Right Cessation
- 2001-08-10 NL NL1018741A patent/NL1018741C1/en not_active IP Right Cessation
-
2003
- 2003-02-21 BG BG107578A patent/BG107578A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR030095A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING CITALOPRAM | |
| PT833618E (en) | PHARMACEUTICAL FORM SOLID FOR ORAL USE | |
| AR049000A1 (en) | FORMULATION FOR DIRECT COMPRESSION AND PROCESS FOR THE PREPARATION OF A DIRECTLY COMPRESSED TABLET | |
| CO5611118A2 (en) | FORMULATIONS OF AZITROMYCIN GRANULATED BY DRY ROUTE | |
| CO5011053A1 (en) | PROCEDURE FOR THE PRODUCTION OF A SOLID DOSAGE FORM CONTAINING CARVEDILOL AND HYDROCLOROTIAZIDA AND PHARMACEUTICAL FORMS OBTAINED BY SUCH PROCEDURE | |
| CO5190688A1 (en) | PHARMACEUTICAL FORMS OF ORAL ADMINISTRATION AT LEAST PARTIALLY DELAYED WHOSE ACTIVE SUBSTANCE TRAMADOL IS AT LEAST PARTIALLY IN THE FORM OF A COMPOSITE FORMED IN SITU WITH A 100 MG / ML HYDROSOLUBILITY, AND PROCEDURES FOR PREPARATION | |
| CL2009001899A1 (en) | Pharmaceutical composition comprising: i) an at1 receptor antagonist or a salt, ii) an insulin sensitizer or a salt and iii) a pharmaceutically acceptable carrier; use for the prevention, delay of progress or treatment of hypertension, diabetes, among others (div. sol. 2034-01). | |
| EE200300033A (en) | Cyclopentanoindoles, their use in the preparation of a medicament, and the pharmaceutical composition containing them | |
| CO5390076A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| AR033688A1 (en) | RECONSTITUABLE PARENTERAL COMPOSITION | |
| AR038143A1 (en) | CORTICOTROPINE LIBERATING FACTOR RECEIVER 2 AGONISTS | |
| CO4940406A1 (en) | QUICK-ACTION PARACETAMOL COMPOSITIONS | |
| BRPI0512756A (en) | combination pharmaceutical composition for pain treatment, pain control method, use of a pharmaceutical composition and packaging including tablets or capsules | |
| SE9003904D0 (en) | METHOD FOR THE MANUFACTURE OF A PHARMACEUTICAL DOSAGE FORM | |
| SE8901003D0 (en) | QUICKLY PREPARATION | |
| AR039221A1 (en) | COMBINATIONS OF EPINASTINE, BELLADONA AND PSEUDOEFEDRINA AS PHARMACEUTICAL FORMULATIONS | |
| BRPI0509971A (en) | a pharmaceutical dosage form, tablet and preparation method | |
| SE0401655D0 (en) | New compounds | |
| CO5261595A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A COMBINATION OF SALMETEROL AND IPRATROPIUM | |
| UY28457A1 (en) | NEW COMPOSITION | |
| BR0307816C1 (en) | oral pharmaceutical composition for vinorelbine soft capsules and treatment method | |
| AR043019A1 (en) | ORAL TRANSMUCOSIDE SOLID DOSAGE FORMS FREE OF SUGAR AND ITS USES | |
| CO5700697A2 (en) | SOLID DOSE FORM | |
| EA200300768A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING CYTALOPRA | |
| MEP39708A (en) | New pharmaceutical compositions containing epinastine and pseudoephedrine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |